Alternatives to Oryon Cell Therapies
Oryon Cell Therapies is a Biotechnology tool: clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Oryon Cell Therapies
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Alcolase85BiotechnologyCopenhagen, DenmarkEnzyme-based technology to break down alcohol in the stomach.
- Website
Supernus Pharmaceuticals60BiotechnologyRockville, United States$17.5MBiopharmaceutical company developing and commercializing CNS disease treatments.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website
Cellares54BiotechnologySouth San Francisco, USA$327.0MThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
Tortugas Neuroscience51BiotechnologyFramingham, USA$164.0MAdvancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
- Website
Cognito Therapeutics50BiotechnologyBoston, USA$213.0MDeveloping a novel therapeutic approach for Alzheimer's disease.
- Website
Lysoway Therapeutics48BiotechnologyCambridge, USA$45.0MDeveloping small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.
- Website
Draig Therapeutics48BiotechnologyNewton, United States$65.0MClinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
- Website
Prostate Cancer Foundation47BiotechnologySanta Monica, USA$63.0MAccelerating breakthroughs in prostate cancer diagnosis and treatment.
- Website
Signadori Bio45BiotechnologyParis, France$12.2MDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
- Website
BioLamina45BiotechnologyStockholm, Sweden$41.9MDeveloping and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.
- Website
Deep Science Ventures44BiotechnologyLondon, United Kingdom$63.0MEmpowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.
- Website
Adaptimmune Therapeutics44BiotechnologyAbingdon, United Kingdom$107.5MBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Aelis Farma43BiotechnologyBordeaux, France$54.3MClinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
- Website
Primogene39BiotechnologyLeipzig, Germany$4.1MEnabling sustainable and scalable manufacturing of complex, high-value biomolecules through enzymatic biomanufacturing.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Showing the 20 closest matches. See the rest on the Oryon Cell Therapies profile.
Compare Oryon Cell Therapies head to head
Side by side on what each one does, what it costs, and what real users report.